Name: Tyrosine-protein kinase BLK Inhibitors (IC50, Ki)
Creator: AAT Bioquest
License: https://www.aatbio.com/tou.html

Tyrosine-protein kinase BLK Inhibitors (IC50, Ki)

Structure	Compound Name	Standard Type	Standard Values (in nM)
	Ibrutinib	IC50	0.5 ^[1]
	Canertinib	IC50	29.0 ^[1], 50.0 ^[2]
	4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline	IC50	5470.0 ^[1], 10000.0 ^[2]
	7-[cis-4-(4-Methylpiperazin-1-Yl)cyclohexyl]-5-(4-Phenoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-4-Amine	IC50	46.0 ^[1], 370.0 ^[2]
	1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one	IC50	19000.0 ^[1]
Rows per page: 1–5 of 92

References

This online resource may be cited as follows

MLA	"Quest Database™ Tyrosine-protein kinase BLK Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Jan. 2026, https://www.aatbio.com/data-sets/tyrosine-protein-kinase-blk-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2026, January 21). Quest Database™ Tyrosine-protein kinase BLK Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/tyrosine-protein-kinase-blk-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan